Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Edward Dempsey

Concepts (333)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neprilysin
6
2017
47
2.310
Why?
Muscle, Smooth, Vascular
22
2017
446
2.200
Why?
Protein Kinase C
15
2007
261
1.750
Why?
Pulmonary Artery
26
2020
1086
1.710
Why?
Hypoxia
18
2021
1112
1.200
Why?
rho GTP-Binding Proteins
2
2020
60
1.170
Why?
Pulmonary Circulation
7
2009
429
0.930
Why?
Isoenzymes
9
2007
304
0.700
Why?
Hypertension, Pulmonary
12
2021
1910
0.660
Why?
Lung
11
2021
4060
0.630
Why?
Evans Blue
1
2018
7
0.600
Why?
Capillary Permeability
1
2018
145
0.570
Why?
Cell Division
25
2009
794
0.550
Why?
Protein Kinase C-epsilon
3
2005
25
0.540
Why?
Myocytes, Smooth Muscle
2
2019
261
0.520
Why?
Muscle Proteins
1
2017
231
0.500
Why?
Blood Vessels
3
2016
187
0.480
Why?
Endothelium, Vascular
2
2020
927
0.420
Why?
Receptor, Platelet-Derived Growth Factor beta
1
2013
29
0.400
Why?
Aging
4
2020
1864
0.400
Why?
Mice, Knockout
6
2017
3015
0.380
Why?
Animals
44
2021
36940
0.380
Why?
Animals, Newborn
10
2007
844
0.360
Why?
Airway Remodeling
1
2010
64
0.330
Why?
Pulmonary Disease, Chronic Obstructive
3
2017
1040
0.310
Why?
Cattle
16
2002
984
0.280
Why?
Fibroblasts
7
2019
996
0.260
Why?
Mice
14
2018
17787
0.250
Why?
Endothelin-1
2
2017
182
0.230
Why?
Protein Kinases
1
2007
319
0.230
Why?
Signal Transduction
7
2020
5079
0.220
Why?
Enzyme Activation
5
2017
810
0.210
Why?
Lung Neoplasms
11
2012
2526
0.210
Why?
rho-Associated Kinases
2
2019
83
0.210
Why?
Cells, Cultured
12
2017
4193
0.200
Why?
Lung Diseases
2
2007
767
0.200
Why?
Potassium Channels, Voltage-Gated
1
2002
50
0.200
Why?
Vascular Endothelial Growth Factor Receptor-2
3
2012
86
0.190
Why?
Insulin-Like Growth Factor I
3
1997
319
0.190
Why?
Vascular Remodeling
2
2021
193
0.190
Why?
Vasoconstriction
1
2002
202
0.180
Why?
Growth Substances
4
1997
147
0.180
Why?
Mice, Inbred C57BL
5
2017
5757
0.180
Why?
Cell Movement
3
2017
967
0.180
Why?
Tetradecanoylphorbol Acetate
5
1997
150
0.180
Why?
Butyrates
1
2021
61
0.170
Why?
Proto-Oncogene Proteins c-myc
2
2020
139
0.170
Why?
Metabolic Diseases
1
2021
108
0.170
Why?
Mitogens
2
1997
61
0.170
Why?
Forkhead Box Protein O3
1
2020
17
0.170
Why?
Vasa Vasorum
1
2020
25
0.160
Why?
Platelet-Derived Growth Factor
3
1997
93
0.160
Why?
Phenotype
5
2017
3196
0.160
Why?
Receptors, G-Protein-Coupled
1
2021
220
0.160
Why?
JNK Mitogen-Activated Protein Kinases
1
2020
162
0.160
Why?
rhoA GTP-Binding Protein
1
2019
86
0.150
Why?
Cellular Microenvironment
1
2019
84
0.150
Why?
Genotype
2
2017
1916
0.150
Why?
Pulmonary Alveoli
2
2012
405
0.150
Why?
Metabolome
1
2021
350
0.150
Why?
Thymidine
5
1996
60
0.140
Why?
ets-Domain Protein Elk-1
1
2017
12
0.140
Why?
Smooth Muscle Myosins
1
2017
6
0.140
Why?
Kruppel-Like Transcription Factors
1
2017
66
0.140
Why?
Actins
3
2017
416
0.130
Why?
Microfilament Proteins
1
2017
133
0.130
Why?
Vascular Diseases
1
2019
243
0.130
Why?
Substance P
1
2016
36
0.130
Why?
Calcium-Binding Proteins
1
2017
218
0.130
Why?
Doxycycline
1
2016
62
0.130
Why?
Duodenum
1
2016
78
0.120
Why?
Chronic Disease
6
2009
1793
0.120
Why?
Neovascularization, Pathologic
5
2020
301
0.120
Why?
Pneumonia
1
2021
639
0.120
Why?
Sleep Apnea Syndromes
2
2013
88
0.120
Why?
Uterus
3
2006
215
0.110
Why?
Carcinogens
2
2012
125
0.110
Why?
In Vitro Techniques
5
2007
1092
0.110
Why?
Myocardium
1
2019
1002
0.110
Why?
Cell Communication
1
1996
315
0.110
Why?
Sputum
3
2005
311
0.110
Why?
Endothelial Cells
3
2021
785
0.100
Why?
Humans
30
2021
137585
0.100
Why?
Estradiol
2
1997
521
0.100
Why?
Enzyme Inhibitors
4
2002
840
0.100
Why?
Gene Expression Regulation, Developmental
1
1997
860
0.100
Why?
Blotting, Western
3
2012
1226
0.100
Why?
Quinazolines
2
2012
251
0.100
Why?
Cell Proliferation
2
2017
2475
0.100
Why?
Piperidines
2
2012
206
0.100
Why?
Gene Expression Regulation
3
2016
2607
0.090
Why?
Bronchoscopy
5
2009
223
0.090
Why?
Gene Expression Regulation, Enzymologic
2
2005
283
0.090
Why?
Mice, Transgenic
1
2016
2167
0.090
Why?
DNA Primers
2
2009
515
0.090
Why?
Somatomedins
1
1990
27
0.080
Why?
Carcinoma in Situ
3
2005
49
0.080
Why?
Arteries
2
2006
269
0.080
Why?
Precancerous Conditions
3
2004
169
0.080
Why?
Maleimides
3
2000
23
0.080
Why?
Isotretinoin
1
2009
26
0.080
Why?
Tocopherols
1
2009
26
0.080
Why?
Cardiovascular Diseases
1
2021
2111
0.080
Why?
Cell Hypoxia
3
1999
226
0.080
Why?
ErbB Receptors
1
2012
614
0.080
Why?
Blood Pressure
3
2021
1786
0.070
Why?
Biomarkers
1
2020
4149
0.070
Why?
Biomarkers, Tumor
3
2012
1276
0.070
Why?
Carcinoma, Squamous Cell
2
2005
683
0.070
Why?
Galectin 1
1
2006
2
0.070
Why?
Female
17
2012
73304
0.070
Why?
Bronchi
2
2000
260
0.070
Why?
Genes, ras
2
1997
97
0.060
Why?
Hyperoxia
1
2007
90
0.060
Why?
Indoles
3
2000
412
0.060
Why?
Videotape Recording
1
2006
35
0.060
Why?
Heart Failure
1
2019
2236
0.060
Why?
Thiazolidinediones
1
2006
137
0.060
Why?
Male
10
2018
67762
0.060
Why?
Hypertrophy, Right Ventricular
2
2021
145
0.060
Why?
Rats, Sprague-Dawley
3
2021
2486
0.060
Why?
Nitric Oxide Synthase Type II
1
2005
173
0.060
Why?
DNA
4
1997
1459
0.060
Why?
Smoking
4
2009
1627
0.060
Why?
Blood
2
1995
107
0.060
Why?
Disease Models, Animal
2
2013
4295
0.060
Why?
Nitric Oxide Synthase Type III
1
2005
204
0.060
Why?
Rats
4
2021
5647
0.060
Why?
Endothelins
2
1996
65
0.060
Why?
Calcium
2
2002
1199
0.050
Why?
Drug Synergism
3
1996
382
0.050
Why?
Guinea Pigs
3
2006
158
0.050
Why?
Hemodynamics
1
2009
1113
0.050
Why?
Bronchoalveolar Lavage Fluid
2
1997
652
0.050
Why?
Drug Delivery Systems
1
2007
365
0.050
Why?
Shaw Potassium Channels
1
2002
4
0.050
Why?
Potassium Chloride
1
2002
38
0.050
Why?
Potassium Channel Blockers
1
2002
37
0.050
Why?
Stem Cells
1
2007
594
0.050
Why?
Fetus
2
1997
806
0.050
Why?
Case-Control Studies
1
2010
3556
0.050
Why?
Intracellular Signaling Peptides and Proteins
1
2005
455
0.050
Why?
Angiotensin II
1
2002
99
0.050
Why?
Nitric Oxide Synthase
1
2002
240
0.050
Why?
Potassium Channels
1
2002
151
0.050
Why?
Tunica Media
2
1998
38
0.050
Why?
Urethane
2
2012
43
0.050
Why?
Protein Kinase C beta
2
2000
21
0.040
Why?
Antineoplastic Agents
2
2010
2129
0.040
Why?
Systole
1
2021
189
0.040
Why?
Gene Deletion
1
2002
391
0.040
Why?
Fluorescence
1
2001
160
0.040
Why?
Tight Junctions
1
2021
76
0.040
Why?
Patient Education as Topic
1
2006
766
0.040
Why?
Acetylation
1
2021
248
0.040
Why?
Microvessels
1
2021
88
0.040
Why?
Receptors, Purinergic P2Y
1
2020
7
0.040
Why?
Macrophages
2
2021
1547
0.040
Why?
Genetic Predisposition to Disease
1
2009
2426
0.040
Why?
Nitric Oxide
1
2005
915
0.040
Why?
Ligands
1
2021
664
0.040
Why?
Aged
6
2010
23961
0.040
Why?
Cytokines
2
2021
2085
0.040
Why?
GTPase-Activating Proteins
1
2019
83
0.040
Why?
Guanine Nucleotide Exchange Factors
1
2019
66
0.040
Why?
Trans-Activators
1
2001
398
0.040
Why?
Light
1
2001
381
0.040
Why?
Up-Regulation
1
2021
843
0.040
Why?
Immune System
1
2019
177
0.040
Why?
Leukocytes
1
2019
311
0.040
Why?
Oxygen
1
2002
931
0.040
Why?
Phosphatidylinositol 3-Kinases
1
2020
366
0.030
Why?
Neoplasms
1
2013
2671
0.030
Why?
Aorta
2
2001
417
0.030
Why?
Culture Media, Serum-Free
1
1997
48
0.030
Why?
Proto-Oncogene Proteins c-sis
1
1997
39
0.030
Why?
Proto-Oncogene Proteins c-akt
1
2020
437
0.030
Why?
Disease Susceptibility
1
2019
347
0.030
Why?
Adenosine Triphosphate
1
2020
491
0.030
Why?
Protein Kinase C-alpha
1
1997
37
0.030
Why?
Ischemia
1
2000
409
0.030
Why?
Organ Specificity
1
1997
305
0.030
Why?
Pregnancy, Animal
1
1997
52
0.030
Why?
Bronchial Neoplasms
1
1996
15
0.030
Why?
TOR Serine-Threonine Kinases
1
2020
412
0.030
Why?
Muscle Development
1
1997
111
0.030
Why?
Sensitivity and Specificity
2
2001
1946
0.030
Why?
Nuclear Proteins
1
2001
712
0.030
Why?
Microcirculation
2
2007
149
0.030
Why?
Species Specificity
1
1997
585
0.030
Why?
Heart Ventricles
1
2021
788
0.030
Why?
Rabbits
1
1997
794
0.030
Why?
Reactive Oxygen Species
1
2019
622
0.030
Why?
Blood Physiological Phenomena
1
1996
13
0.030
Why?
Receptors, Platelet-Derived Growth Factor
1
1996
15
0.030
Why?
Tritium
1
1996
76
0.030
Why?
Point Mutation
1
1997
235
0.030
Why?
Middle Aged
5
2010
33479
0.030
Why?
Dose-Response Relationship, Drug
2
2010
2057
0.030
Why?
Rats, Inbred Strains
1
1996
362
0.030
Why?
Neoplasms, Second Primary
1
1997
118
0.030
Why?
DNA Mutational Analysis
1
1996
399
0.030
Why?
Protein Precursors
1
1996
134
0.030
Why?
Myocytes, Cardiac
1
2019
526
0.030
Why?
Catalysis
1
1995
307
0.030
Why?
Subcellular Fractions
1
1994
82
0.030
Why?
Adenosine Diphosphate
1
1994
79
0.030
Why?
Clinical Trials as Topic
1
2019
1050
0.030
Why?
Models, Biological
1
2021
1783
0.030
Why?
Exercise
1
2006
2057
0.030
Why?
Flow Cytometry
2
1996
1178
0.030
Why?
Quality of Life
1
2006
2892
0.030
Why?
Recombinant Proteins
1
1997
1353
0.030
Why?
Stress, Mechanical
1
1996
485
0.030
Why?
Poly I-C
1
1994
63
0.030
Why?
Blood Proteins
1
1996
252
0.030
Why?
Young Adult
1
2010
13209
0.030
Why?
Endothelin Receptor Antagonists
1
1993
62
0.030
Why?
Hyperplasia
2
2006
175
0.030
Why?
Complement Factor B
1
1994
109
0.030
Why?
Neoplasm Proteins
1
1996
434
0.030
Why?
Receptors, Estrogen
1
1996
436
0.020
Why?
Methylcholanthrene
1
2012
22
0.020
Why?
Risk Factors
5
2009
10388
0.020
Why?
Butylated Hydroxytoluene
1
2012
38
0.020
Why?
Extracellular Matrix
2
2006
528
0.020
Why?
Serotonin
1
1994
323
0.020
Why?
Immunoenzyme Techniques
1
2012
219
0.020
Why?
Peptides, Cyclic
1
1993
259
0.020
Why?
Time Factors
2
2007
6828
0.020
Why?
Apoptosis
1
2000
2553
0.020
Why?
Phorbol 12,13-Dibutyrate
1
1991
8
0.020
Why?
Cell Count
2
2006
324
0.020
Why?
Aerobiosis
1
1991
21
0.020
Why?
Pregnancy
3
2006
6763
0.020
Why?
Dimethyl Sulfoxide
1
1991
41
0.020
Why?
Adolescent
1
2010
21513
0.020
Why?
Anaerobiosis
1
1991
64
0.020
Why?
Blood Platelets
1
1994
408
0.020
Why?
Infant, Newborn
2
2007
6079
0.020
Why?
Epithelial-Mesenchymal Transition
1
2012
209
0.020
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
243
0.020
Why?
Tumor Cells, Cultured
3
1996
955
0.020
Why?
Chemoprevention
1
2010
92
0.020
Why?
Biopsy
2
2005
1129
0.020
Why?
Protein Binding
1
1996
2224
0.020
Why?
DNA Replication
1
1991
238
0.020
Why?
Antioxidants
1
2012
584
0.020
Why?
RNA, Messenger
1
1996
2833
0.020
Why?
Down-Regulation
1
1990
657
0.020
Why?
Leukocyte Common Antigens
1
2007
87
0.020
Why?
Kinetics
1
1991
1670
0.020
Why?
Molecular Targeted Therapy
1
2010
411
0.020
Why?
Rats, Inbred WKY
1
2006
36
0.020
Why?
Elastin
1
2006
78
0.020
Why?
Proto-Oncogene Proteins c-kit
1
2006
67
0.020
Why?
Codon
2
1997
89
0.020
Why?
PPAR gamma
1
2006
182
0.020
Why?
Serum
1
2006
59
0.020
Why?
Aged, 80 and over
2
2009
7635
0.010
Why?
Vascular Resistance
1
2006
375
0.010
Why?
Chi-Square Distribution
1
2006
530
0.010
Why?
Collagen
1
2006
452
0.010
Why?
Protein Kinase Inhibitors
1
2010
916
0.010
Why?
Sheep
1
2006
856
0.010
Why?
Teaching
1
2006
224
0.010
Why?
Polymerase Chain Reaction
2
1997
1062
0.010
Why?
Confidence Intervals
1
2004
329
0.010
Why?
Neoplasm Invasiveness
1
2005
510
0.010
Why?
Antibodies, Monoclonal
1
2010
1430
0.010
Why?
Adenocarcinoma
1
2010
940
0.010
Why?
Vital Capacity
1
2004
311
0.010
Why?
Epithelial Cells
2
2001
1096
0.010
Why?
Base Sequence
1
2006
2181
0.010
Why?
Forced Expiratory Volume
1
2004
531
0.010
Why?
Neoplasm Recurrence, Local
1
2009
1079
0.010
Why?
Activities of Daily Living
1
2006
413
0.010
Why?
Gestational Age
1
2006
910
0.010
Why?
Bronchopulmonary Dysplasia
1
2007
383
0.010
Why?
Patient Compliance
1
2006
581
0.010
Why?
CREB-Binding Protein
1
2001
31
0.010
Why?
Metaplasia
1
2001
60
0.010
Why?
Single-Blind Method
1
2001
282
0.010
Why?
Adaptation, Psychological
1
2006
655
0.010
Why?
Fluorescent Antibody Technique
1
2001
390
0.010
Why?
Chromosomes, Human, Pair 3
1
2000
50
0.010
Why?
Loss of Heterozygosity
1
2000
51
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
52
0.010
Why?
Ki-67 Antigen
1
2000
112
0.010
Why?
Airway Obstruction
1
2001
162
0.010
Why?
Carcinoma
1
2001
240
0.010
Why?
Fibrosis
1
2002
552
0.010
Why?
Risk
1
2001
912
0.010
Why?
Cell Death
1
2000
374
0.010
Why?
Prevalence
1
2005
2734
0.010
Why?
Carcinoma, Non-Small-Cell Lung
2
1997
1081
0.010
Why?
Mitotic Index
1
1997
25
0.010
Why?
Bromodeoxyuridine
1
1997
79
0.010
Why?
Cytoskeletal Proteins
1
1997
158
0.010
Why?
Mammals
1
1999
283
0.010
Why?
Tunica Intima
1
1997
84
0.010
Why?
Chromosome Banding
1
1996
19
0.010
Why?
Myosins
1
1997
135
0.010
Why?
Ploidies
1
1996
18
0.010
Why?
Karyotyping
1
1996
104
0.010
Why?
Ligases
1
1996
32
0.010
Why?
Ovariectomy
1
1997
152
0.010
Why?
Comorbidity
1
2001
1622
0.010
Why?
Bronchoalveolar Lavage
1
1996
93
0.010
Why?
Heparin
1
1997
261
0.010
Why?
Tumor Suppressor Protein p53
1
2000
528
0.010
Why?
Immunohistochemistry
1
2000
1738
0.010
Why?
Immunophenotyping
1
1996
318
0.010
Why?
Regional Blood Flow
1
1997
474
0.010
Why?
Transcription, Genetic
1
2001
1457
0.010
Why?
HeLa Cells
1
1996
636
0.010
Why?
Calcimycin
1
1994
49
0.010
Why?
Epidermal Growth Factor
1
1994
177
0.010
Why?
Mice, Inbred C3H
1
1994
269
0.010
Why?
Interferon-beta
1
1994
92
0.010
Why?
Surveys and Questionnaires
1
2006
5778
0.010
Why?
Cell Survival
1
1996
1120
0.010
Why?
Mass Screening
1
2001
1287
0.010
Why?
Neoplasm Staging
1
1997
1389
0.010
Why?
Prognosis
1
2001
4030
0.010
Why?
Adult
2
2009
37929
0.010
Why?
Macrophage Activation
1
1994
201
0.010
Why?
Analysis of Variance
1
1993
1316
0.010
Why?
Interferon-gamma
1
1994
789
0.010
Why?
Mutation
1
2000
3958
0.000
Why?
Peptides
1
1994
985
0.000
Why?
Tumor Necrosis Factor-alpha
1
1994
1242
0.000
Why?
Retrospective Studies
1
2005
15657
0.000
Why?
Dempsey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)